Medscape3d
Subcutaneous Guselkumab Proves Efficacious for IBD in Two Studies: ASTRO and GRAVITI
For both induction and maintenance therapy, subcutaneous guselkumab significantly improves clinical outcomes in patients with ...
manilatimes4d
TREMFYA® (guselkumab) receives positive CHMP opinion for treatment of adult patients with moderately to severely active ulcerative colitis
A Phase 2b/3, randomised, double-blind, placebo-controlled, parallel-group, multicentre protocol to evaluate the efficacy and safety of guselkumab in participants with moderately to severely active ...
PMLiVE5d
J&J’s shares positive results for subcutaneous Tremfya in phase 3 ulcerative colitis trial
Johnson & Johnson (J&J) has shared positive results from a late-stage study evaluating a subcutaneous (SC) version of Tremfya ...
pharmaphorum5d
Lilly nets a second FDA okay for Omvoh, in Crohn's disease
and Tremfya (guselkumab), and Sun Pharma's Ilumya (tildrakizumab). In Crohn's, Skyrizi, Stelara, and Ilumya are already approved by the FDA, while Tremfya is under review, having been submitted to ...
pharmaphorum4d
AbbVie adds psoriasis med with Nimble takeover
and Tremfya (guselkumab), Eli Lilly's Omvoh (mirikizumab), and Sun Pharma's Ilumya (tildrakizumab). Oral IL-23-directed alternatives are starting to filter through the industry pipeline that aim ...
manilatimes3d
AIM announces Paul Goepfert, MD, as the principal investigator for the planned clinical study of Ampligen and FluMist as a vaccine for avian influenza
Paul Goepfert, MD, Director for the Alabama Vaccine Research Clinic, stated: "I'm excited for the opportunity to follow-up on ...
Yahoo Finance4d
Johnson & Johnson (JNJ)
After hours: 28 February at 7:58:44 pm GMT-5 ...
verywellhealth3d
Psoriasis vs. Eczema vs. Rosacea: Know the Difference
Severe cases may require treatment with powerful psoriasis medications, including: Trexall (methotrexate) Sandimmune (cyclosporine) Biologic drugs, including Enbrel (etanercept), Remicade (infliximab) ...